Radiation Oncology/RTOG Trials/0415

RTOG 04-15 (PROSTATE)
 * Radiation_Oncology/Prostate/RTOG_Prostate


 * Title: A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients With Favorable-Risk Prostate Cancer
 * Objective: Compare the disease-free survival (DFS) of patients with favorable-risk stage II prostate cancer treated with hypofractionated vs conventionally fractionated three-dimensional conformal radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT).
 * Protocol:
 * Arm 1: 73.8 Gy in 41 fractions
 * Arm 2: 70 Gy in 28 fractions
 * Eligibility:
 * T1-2c N0 M0, Gleason 2-6, PSA < 10
 * Enrollment Target: 1067 patients
 * Activated: April 18, 2006
 * Closed: December 11, 2009
 * Clinicaltrials.gov